Imagery Rescripting in Primary Care
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Amsterdam
About this trial
In the current study we aim to investigate the feasibility, acceptability, and effectiveness of ImRs offered by mental health assistants within primary care to reduce depressive symptoms. In a single-case experimental design (SCED) study, the following hypotheses will be tested:
1. ImRs results in a reduction of depressive symptoms compared to baseline, and this reduction lasts up to six months. 2. Patients with complaints of depressive symptoms find ImRs an acceptable form of intervention when offered by mental health assistants within a general practice setting.
Participants will wait for 2-4 weeks and then receive 5 sessions of ImRs over a period of 10 weeks. During these sessions, negative memories related to their depressed feelings are rescripted.
Eligibility criteria
Qualifiers
Main complaint of depressive feelings, as indicated by both the mental health assistant and the patient.
HADS score for the depression subscale ≥ 11.
Ability to understand, read, write and speak Dutch or English.
Age between 18 and 70.
Disqualifiers
Acute suicide risk (BDI-II-item9 score of 3).
If the mental health assistant suspects that the patient may have a primary diagnosis of bipolar disorder, psychosis, substance use disorder, low IQ, or if the patient suffers from serious neurological problems such as dementia, then the patient is not included. There will not be a formal assessment of a primary diagnosis.
Trial design
Treatments tested in this trial
- Imagery Rescripting
Treatment groups
12 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Amsterdam
Lead sponsor
UvA Huisartsen
Collaborator
Source ClinicalTrials.gov